We found that all the hypertrophic cardiomyopathy markers (ANP, BNP, and β‐MHC) were significantly increased in TAC‐treated mice and overexpression of MIF in TAC‐treated mice attenuated the increases of these markers (Figure 1g,h). The gene discussed is NPPA; the disease is hypertrophic cardiomyopathy.